• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A steady-state mass transfer model of removing CPAs from cryopreserved blood with hollow fiber modules.一种使用中空纤维模块从冷冻保存血液中去除 CPA 的稳态传质模型。
J Biomech Eng. 2010 Jan;132(1):011002. doi: 10.1115/1.4000110.
2
Statistical estimation of red blood cell osmotic damage during cryoprotective agent removal from cryopreserved blood.从冷冻保存血液中去除冷冻保护剂期间红细胞渗透损伤的统计学估计。
Biopreserv Biobank. 2013 Oct;11(5):299-308. doi: 10.1089/bio.2013.0028.
3
Theoretical optimization of the removal of cryoprotective agents using a dilution-filtration system.使用稀释-过滤系统去除冷冻保护剂的理论优化
Biomed Eng Online. 2014 Aug 21;13:120. doi: 10.1186/1475-925X-13-120.
4
A dilution-filtration system for removing cryoprotective agents.一种用于去除冷冻保护剂的稀释-过滤系统。
J Biomech Eng. 2011 Feb;133(2):021007. doi: 10.1115/1.4003317.
5
Effect of the polydispersity of RBCs on the recovery rate of RBCs during the removal of CPAs.红细胞多分散性对去除 CPA 过程中红细胞回收率的影响。
Comput Math Methods Med. 2014;2014:792302. doi: 10.1155/2014/792302. Epub 2014 Dec 15.
6
Hydrogel Microfiber Encapsulation Enhances Cryopreservation of Human Red Blood Cells with Low Concentrations of Glycerol.水凝胶微纤维包封增强低浓度甘油对人红细胞的冷冻保存。
Biopreserv Biobank. 2020 Jun;18(3):228-234. doi: 10.1089/bio.2020.0003. Epub 2020 Apr 21.
7
Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.人类血小板冷冻保存最佳技术的发展。I. 冷藏(22摄氏度和8摄氏度)及冷冻保存期间的血小板活化
Cryobiology. 1999 May;38(3):225-35. doi: 10.1006/cryo.1999.2162.
8
Comparison of dilute and nondilute osmotic equilibrium models for erythrocytes.红细胞稀溶液和非稀溶液渗透平衡模型的比较。
Cryobiology. 2022 Dec;109:72-79. doi: 10.1016/j.cryobiol.2022.09.001. Epub 2022 Sep 18.
9
Polyampholytes as cryoprotective agents for mammalian cell cryopreservation.多两性电解质作为哺乳动物细胞低温保存的保护剂。
Cell Transplant. 2010;19(6):691-9. doi: 10.3727/096368910X508780. Epub 2010 Jun 3.
10
Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.使用冷冻保存移植物的造血干细胞移植:移植后的不良反应及输注前的冷冻保护剂去除
Bone Marrow Transplant. 2014 Apr;49(4):469-76. doi: 10.1038/bmt.2013.152. Epub 2013 Sep 30.

引用本文的文献

1
Incorporate delivery, warming and washing methods into efficient cryopreservation.将递送、升温及清洗方法融入高效冷冻保存过程中。
Front Bioeng Biotechnol. 2023 Jun 15;11:1215591. doi: 10.3389/fbioe.2023.1215591. eCollection 2023.
2
Cryopreservation of Hematopoietic Stem Cells: Emerging Assays, Cryoprotectant Agents, and Technology to Improve Outcomes.造血干细胞的冷冻保存:改善结果的新兴检测方法、冷冻保护剂和技术
Transfus Med Hemother. 2019 Jun;46(3):188-196. doi: 10.1159/000496068. Epub 2019 Feb 5.
3
Effect of the polydispersity of RBCs on the recovery rate of RBCs during the removal of CPAs.红细胞多分散性对去除 CPA 过程中红细胞回收率的影响。
Comput Math Methods Med. 2014;2014:792302. doi: 10.1155/2014/792302. Epub 2014 Dec 15.
4
Theoretical optimization of the removal of cryoprotective agents using a dilution-filtration system.使用稀释-过滤系统去除冷冻保护剂的理论优化
Biomed Eng Online. 2014 Aug 21;13:120. doi: 10.1186/1475-925X-13-120.
5
Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.使用冷冻保存移植物的造血干细胞移植:移植后的不良反应及输注前的冷冻保护剂去除
Bone Marrow Transplant. 2014 Apr;49(4):469-76. doi: 10.1038/bmt.2013.152. Epub 2013 Sep 30.

本文引用的文献

1
Water- and cryoprotectant-permeability of mature and immature oocytes in the medaka (Oryzias latipes).青鳉成熟和未成熟卵母细胞的水通透性及冷冻保护剂通透性
Cryobiology. 2005 Feb;50(1):93-102. doi: 10.1016/j.cryobiol.2004.11.002. Epub 2005 Jan 20.
2
Cryoprotectant permeability parameters for cells used in a bioengineered human corneal equivalent and applications for cryopreservation.用于生物工程化人角膜等效物的细胞的冷冻保护剂渗透性参数及冷冻保存应用
Cryobiology. 2004 Oct;49(2):169-80. doi: 10.1016/j.cryobiol.2004.06.005.
3
The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.自体移植前二甲基亚砜清除的作用:对血液学恢复、副作用及毒性的影响
Biol Blood Marrow Transplant. 2004 Feb;10(2):135-41. doi: 10.1016/j.bbmt.2003.09.016.
4
OSMOTIC PROPERTIES OF HUMAN RED CELLS.人类红细胞的渗透特性。
J Gen Physiol. 1964 Sep;48(1):79-94. doi: 10.1085/jgp.48.1.79.
5
Thermodynamic analysis of the permeability of biological membranes to non-electrolytes.生物膜对非电解质渗透性的热力学分析
Biochim Biophys Acta. 1958 Feb;27(2):229-46. doi: 10.1016/0006-3002(58)90330-5.
6
Membrane permeability characteristics and osmotic tolerance limits of sea urchin (Evechinus chloroticus) eggs.海胆(Evechinus chloroticus)卵的膜通透性特征及渗透耐受极限
Cryobiology. 2003 Aug;47(1):1-13. doi: 10.1016/s0011-2240(03)00063-4.
7
Use of hollow fiber membrane filtration for the removal of DMSO from platelet concentrates.使用中空纤维膜过滤法从血小板浓缩物中去除二甲基亚砜。
Platelets. 2003 May;14(3):131-7. doi: 10.1080/0953710031000092811.
8
Measurement of the chondrocyte membrane permeability to Me2SO, glycerol and 1,2-propanediol.软骨细胞对二甲基亚砜、甘油和1,2 - 丙二醇的细胞膜通透性测量。
Med Eng Phys. 2003 Sep;25(7):573-9. doi: 10.1016/s1350-4533(03)00073-0.
9
Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.一种自动封闭式液体管理装置Cytomate用于解冻后从造血干细胞移植物中洗去二甲基亚砜的临床前评估。
Bone Marrow Transplant. 2003 May;31(9):823-8. doi: 10.1038/sj.bmt.1703905.
10
Canine RBC osmotic tolerance and membrane permeability.犬红细胞的渗透耐受性和膜通透性。
Cryobiology. 2002 Jun;44(3):258-68. doi: 10.1016/s0011-2240(02)00032-9.

一种使用中空纤维模块从冷冻保存血液中去除 CPA 的稳态传质模型。

A steady-state mass transfer model of removing CPAs from cryopreserved blood with hollow fiber modules.

作者信息

Ding Weiping, Zhou Xiaoming, Heimfeld Shelly, Reems Jo-Anna, Gao Dayong

机构信息

Department of Mechanical Engineering, University of Washington, Seattle, WA 98195, USA.

出版信息

J Biomech Eng. 2010 Jan;132(1):011002. doi: 10.1115/1.4000110.

DOI:10.1115/1.4000110
PMID:20524740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2882658/
Abstract

Hollow fiber modules are commonly used to conveniently and efficiently remove cryoprotective agents (CPAs) from cryopreserved cell suspensions. In this paper, a steady-state model coupling mass transfers across cell and hollow fiber membranes is theoretically developed to evaluate the removal of CPAs from cryopreserved blood using hollow fiber modules. This steady-state model complements the unsteady-state model, which was presented in our previous study. The steady-state model, unlike the unsteady-state model, can be used to evaluate the effect of ultrafiltration flow rates on the clearance of CPAs. The steady-state model is validated by experimental results, and then is compared with the unsteady-state model. Using the steady-state model, the effects of ultrafiltration flow rates, NaCl concentrations in dialysate, blood flow rates and dialysate flow rates on CPA concentration variation and cell volume response are investigated in detail. According to the simulative results, the osmotic damage of red blood cells can easily be reduced by increasing ultrafiltration flow rates, increasing NaCl concentrations in dialysate, increasing blood flow rates, or decreasing dialysate flow rates.

摘要

中空纤维模块通常用于方便、高效地从冷冻保存的细胞悬液中去除冷冻保护剂(CPA)。本文从理论上建立了一个耦合细胞与中空纤维膜传质的稳态模型,以评估使用中空纤维模块从冷冻保存的血液中去除CPA的效果。该稳态模型补充了我们之前研究中提出的非稳态模型。与非稳态模型不同,稳态模型可用于评估超滤流速对CPA清除率的影响。通过实验结果对稳态模型进行了验证,并与非稳态模型进行了比较。利用稳态模型,详细研究了超滤流速、透析液中NaCl浓度、血流速度和透析液流速对CPA浓度变化和细胞体积响应的影响。根据模拟结果,通过提高超滤流速、提高透析液中NaCl浓度、提高血流速度或降低透析液流速,可以很容易地降低红细胞的渗透损伤。